Found: 2
Select item for more details and to access through your institution.
Scoparone inhibits the development of hepatocellular carcinoma by modulating the p38 MAPK/Akt/NF‐κB signaling in nonalcoholic fatty liver disease mice.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 2, p. 551, doi. 10.1002/tox.23851
- By:
- Publication type:
- Article
Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12780-y
- By:
- Publication type:
- Article